☆ 4.5 Editorial Material

Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association and the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction The myPACE Randomized Clinical Trial

Margaret Infeld et al.

Summary: This study found that among patients with HFpEF and pacemakers, treatment with a moderately accelerated, personalized pacing rate was safe and improved quality of life, NT-proBNP levels, physical activity, and atrial fibrillation compared with the usual 60 bpm setting.

JAMA CARDIOLOGY (2023)

Add to Collection
Article Medicine, General & Internal

Rate-Adaptive Atrial Pacing for Heart Failure With Preserved Ejection Fraction The RAPID-HF Randomized Clinical Trial

Yogesh N. V. Reddy et al.

Summary: In patients with HFpEF and chronotropic incompetence, implanting and programming a pacemaker for rate-adaptive atrial pacing did not improve exercise performance and was associated with increased adverse events.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection
Article Cardiac & Cardiovascular Systems

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Xiaowen Wang et al.

Summary: This study analyzed the efficacy and safety of sodium-glucose cotransporter-2 inhibitors in the treatment of heart failure, and assessed the impact of sex on their effectiveness and safety. The study found that, after adjusting for baseline differences, women had fewer cardiovascular and all-cause deaths, as well as lower rates of HF hospitalizations and total events, compared to men. There were no sex-related differences in adverse events or drug discontinuation. Therefore, sex does not modify the treatment effect of sodium-glucose cotransporter-2 inhibitors.

CIRCULATION (2023)

Add to Collection
Article Cardiac & Cardiovascular Systems

Functional Tricuspid Regurgitation and Right Atrial Remodeling in Heart Failure With Preserved Ejection Fraction

Tomonari Harada et al.

Summary: In patients with HFpEF, TR is associated with right atrial remodeling, and the presence of AFTR is linked to poor clinical outcomes. The data emphasize the importance of right atrial remodeling in the pathophysiology of TR in HFpEF.

AMERICAN JOURNAL OF CARDIOLOGY (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial

Gerasimos Filippatos et al.

Summary: Finerenone reduces the incidence of new-onset HF and improves other HF outcomes in patients with chronic kidney disease and type 2 diabetes, regardless of a history of HF.

CIRCULATION (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

Javed Butler et al.

Summary: The impact of empagliflozin on heart failure outcomes was consistent and clinically meaningful in patients with ejection fractions <25% to <65%, but attenuated in those with ejection fraction >= 65%.

EUROPEAN HEART JOURNAL (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Revascularization in ischaemic heart failure with preserved ejection fraction: a nationwide cohort study

Salil Deo et al.

Summary: This study investigated the long-term outcomes of coronary artery bypass grafting (CABG) in patients with heart failure and significant coronary artery disease. It found that patients with preserved ejection fraction had similar long-term survival to controls, but were at increased risk for heart failure hospitalizations and future myocardial infarction.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Theresa A. McDonagh et al.

Summary: All experts involved in the development of the guidelines have declared their interests, and the declarations have been compiled and published in a supplementary report. The report can be accessed on the ESC website. The supplementary data provide background information and detailed discussion of the data that form the basis for the guidelines.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON-HF

Alexander Peikert et al.

Summary: The study found that sacubitril/valsartan similarly attenuates the decline of eGFR and reduces clinically relevant kidney events among patients with HFpEF with and without diabetes, compared to renin-angiotensin system inhibitors alone.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Add to Collection
Review Cardiac & Cardiovascular Systems

Effects of different exercise programs on the cardiorespiratory reserve in HFpEF patients: a systematic review and meta-analysis

Aristi Boulmpou et al.

Summary: HFpEF is a heterogeneous syndrome with complex pathophysiological substrates and multiple clinical manifestations. Recent studies have shown that cardiac rehabilitation programs for HFpEF patients can significantly improve peak oxygen uptake and 6-minute walking test distance, and high-intensity interval training may offer greater enhancement of exercise capacity compared to standard aerobic exercise.

HELLENIC JOURNAL OF CARDIOLOGY (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Criteria for Iron Deficiency in Patients With Heart Failure

Gabriele Masini et al.

Summary: Different definitions of iron deficiency (ID) lead to inconsistent prevalence and prognosis. Definitions lacking specificity may attenuate the benefits of intravenous iron therapy, while definitions lacking sensitivity may exclude patients who should receive intravenous iron therapy.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection
Editorial Material Geriatrics & Gerontology

Scoring the physical frailty phenotype of patients with heart failure

Masaaki Konishi

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Add to Collection
Review Cardiac & Cardiovascular Systems

Physical Exercise Modalities for the Management of Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis

Yuan Guo et al.

Summary: This study conducted a systematic review and meta-analysis to assess the efficacy of different physical exercise modalities in managing heart failure with preserved ejection fraction (HFpEF). The analysis showed that physical exercise significantly improved exercise capacity, quality of life, and certain indicators of cardiac diastolic function in patients with HFpEF. Moderate-intensity exercise training had a superior effect compared to high-intensity training. The duration of exercise was also partially correlated with the improvement in exercise capacity.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Time in Target Range for Systolic Blood Pressure and Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction

Rihua Huang et al.

Summary: This study found that longer time in target range of systolic blood pressure was statistically associated with a decreased risk of cardiovascular outcomes and mortality events among patients with heart failure with preserved ejection fraction. This association was more significant in younger patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction DELIVER Trial

Scott D. Solomon et al.

Summary: This report describes the baseline clinical profiles and management of DELIVER trial participants and how these compare with those in other contemporary heart failure with preserved ejection fraction trials.

JACC-HEART FAILURE (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age

Michael Boehm et al.

Summary: This study evaluated the effects of empagliflozin, a glucose-lowering medication, in patients with heart failure and preserved ejection fraction, with a focus on age. The results showed that empagliflozin reduced the risk of cardiovascular death or heart failure hospitalization in patients of all age groups and improved symptoms and quality of life. There were no significant differences in safety between age groups.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection
Editorial Material Endocrinology & Metabolism

What's preventing us from curbing the obesity crisis?

[Anonymous]

LANCET DIABETES & ENDOCRINOLOGY (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

Javed Butler et al.

Summary: This study evaluated the influence of sex on the effects of empagliflozin in patients with HF and preserved ejection fraction. The results showed that empagliflozin reduced the risk of cardiovascular death or hospitalization for HF to a similar degree in both men and women. Sex did not modify the relationship between empagliflozin and outcomes across ejection fraction groups.

CIRCULATION (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes

Gerasimos Filippatos et al.

Summary: In patients with heart failure and preserved ejection fraction, empagliflozin significantly reduces the risk of heart failure outcomes, regardless of diabetes status at baseline.

CIRCULATION (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial

Michael Boehm et al.

Summary: This study found that empagliflozin reduces the risk of cardiovascular death or heart failure hospitalization in patients with heart failure and preserved ejection fraction. Adverse events related to resting heart rate did not differ significantly between empagliflozin and placebo.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Add to Collection
Article Medicine, General & Internal

Tirzepatide Once Weekly for the Treatment of Obesity

Ania M. Jastreboff et al.

Summary: In this 72-week trial in participants with obesity, once-weekly doses of 5 mg, 10 mg, or 15 mg of tirzepatide provided substantial and sustained reductions in body weight, and improvements in cardiometabolic measures were also observed.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction

Liam Gaziano et al.

Summary: This study aimed to develop race-specific and sex-specific risk prediction models for HFpEF and HFrEF, finding that these models demonstrated good calibration and discrimination in various race and sex strata in the validation cohort.

ESC HEART FAILURE (2022)

Add to Collection
Article Medicine, General & Internal

Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension

Charles Faselis et al.

Summary: The study suggests that among patients with HFpEF and hypertension, lowering the target SBP to <130mmHg is not associated with outcomes, but lowering it to <120mmHg may increase the risk of death while not affecting readmission. Future prospective studies are needed to evaluate optimal SBP treatment goals for these patients.

AMERICAN JOURNAL OF MEDICINE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from theRELAX-AHF-2 study

Siting Feng et al.

Summary: The study found that the incidence of WRF during AHF hospitalization increases progressively with LVEF, especially in patients with higher LVEF. Age and comorbidity burden, such as chronic kidney disease, increased as LVEF increased. The increased risk of WRF in patients with higher LVEF was more related to their advanced age and worse underlying kidney function rather than haemodynamic or treatment effects.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis

Darren K. McGuire et al.

Summary: SGLT2 inhibitors were found to reduce the risk of major adverse CV events and showed significant heterogeneity in associations with CV death. The most consistent benefit of this class of drugs was a reduction in risk for heart failure and kidney outcomes, with heart failure risk reduction being the most consistent observation across the trials.

JAMA CARDIOLOGY (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Ejection fraction and mortality: a nationwide register-based cohort study of 499 153 women and men

Simon Stewart et al.

Summary: When investigating the sex-based risk of mortality across different ranges of left ventricular ejection fraction (LVEF) in a large cohort of Australian patients, it was found that women had a higher risk of mortality at higher LVEF levels.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection
Article Medicine, General & Internal

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

Deepak L. Bhatt et al.

Summary: The trial involving 10,584 patients with diabetes and chronic kidney disease showed that sotagliflozin resulted in fewer deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure compared to placebo. However, there were adverse events such as diarrhea, mycotic infections, and diabetic ketoacidosis associated with sotagliflozin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Article Medicine, General & Internal

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

Deepak L. Bhatt et al.

Summary: In patients with diabetes and recent worsening heart failure, treatment with sotagliflozin significantly reduced the total number of deaths from cardiovascular causes and hospitalizations and urgent visits for heart failure compared to placebo, regardless of the timing of administration.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Right atrial volume is a major determinant of tricuspid annulus area in functional tricuspid regurgitation: a three-dimensional echocardiographic study

Denisa Muraru et al.

Summary: This study aimed to explore the relationship between tricuspid annulus area (TAA) and right atrial maximal volume (RAVmax) and right ventricular end-diastolic volume (RVEDV) in healthy subjects and patients with functional tricuspid regurgitation (FTR) of different etiologies and severities. The study found that RAVmax is the main determinant of TAA, and right atrial enlargement is an important mechanism of TAA dilation in FTR patients, regardless of the underlying conditions causing the FTR.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction

Patricia Palau et al.

Summary: This study aimed to evaluate the effect of beta-blocker withdrawal on peak oxygen consumption in patients with heart failure with preserved ejection fraction (HFpEF) and chronotropic incompetence. The results showed that beta-blocker withdrawal significantly improved maximal functional capacity in these patients.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction

Emil Wolsk et al.

Summary: The study found heterogeneity in heart rate and stroke volume responses to exercise in patients with HFpEF, with a high proportion showing chronotropic incompetence and impaired increase in stroke volume. Factors such as body mass index and resting heart rate were associated with smaller increases in heart rate during exercise, while resting heart rate and medication use were associated with greater increase in stroke volume in HFpEF patients.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

Biykem Bozkurt et al.

Summary: This document proposes a universal definition of heart failure as a clinical syndrome and revised stages of HF, as well as a new classification based on left ventricular ejection fraction (LVEF) levels. The classification includes HFrEF, HFmrEF, HFpEF, and HFimpEF based on LVEF percentages.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection
Article Medicine, General & Internal

Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial

Stephan Mueller et al.

Summary: This study showed that high-intensity interval training and moderate continuous training did not result in significant differences in peak oxygen consumption compared to guideline-based physical activity in patients with heart failure with preserved ejection fraction.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function

Iris E. Beldhuis et al.

Summary: Among patients with HFpEF, spironolactone increased the risk of WRF compared to placebo, but rates of cardiovascular death were lower with spironolactone in both patients with and without WRF.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection
Article Medicine, General & Internal

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John P. H. Wilding et al.

Summary: The study demonstrates that for individuals with obesity, once-weekly use of 2.4 mg semaglutide in combination with lifestyle intervention can lead to sustained and clinically relevant weight loss, with significant improvements in cardiometabolic risk factors and physical functioning reported by participants.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Impact of Chronic Obstructive Pulmonary Disease in Heart Failure With Preserved Ejection Fraction

Snigdha Jain et al.

Summary: Individuals with co-morbid HFpEF and COPD exhibit more severe systemic large artery stiffening, LV remodeling, and LV fibrosis compared to those with either condition alone.

AMERICAN JOURNAL OF CARDIOLOGY (2021)

Add to Collection
Editorial Material Cardiac & Cardiovascular Systems

Heart Failure with Supra-normal Left Ventricular Ejection Fraction State of the Art

Ziyin Huang et al.

Summary: HFsnEF, a new phenotype of heart failure with supra-normal left ventricular ejection fraction, is associated with higher all-cause mortality compared to other HF patients. Future research is needed to better understand and treat this new phenotype.

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Implications of Atrial Fibrillation on the Mechanisms of Mitral Regurgitation and Response to MitraClip in the COAPT Trial

Zachary M. Gertz et al.

Summary: In the COAPT trial, patients with a history of AF had larger left atrial and mitral valve orifice areas with higher LV ejection fraction and smaller LV volumes. Despite the worse prognosis of heart failure patients with a history of AF, MR reduction with the MitraClip still afforded substantial clinical benefits. Treatment with MitraClip was associated with a lower risk of stroke in patients with a history of AF.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Global Differences in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial

Jasper Tromp et al.

Summary: In the PARAGON-HF trial, regional differences in clinical characteristics and outcomes were observed among patients with HFpEF, which may have implications for the design of future clinical trials.

CIRCULATION-HEART FAILURE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings

Sara Hadzibegovic et al.

Summary: Hospitalized COVID-19 patients often exhibit a high likelihood of HFpEF-like syndrome, which is linked to cardiac structural and functional changes, as well as myocardial injury. Detailed cardiac assessments, including echocardiographic evaluation of left ventricular diastolic function and biomarkers, should be routinely performed in the management of hospitalized COVID-19 patients.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy

Ana Devesa et al.

Summary: The prevalence of transthyretin (TTR) cardiac amyloidosis in heart failure patients with preserved ejection fraction (HFpEF) without left ventricular hypertrophy (LVH) was found to be 5%. Early diagnosis of cardiac involvement in TTR amyloidosis before manifest LVH is recommended due to newly approved specific treatments that can prevent additional deposition of amyloid material.

ESC HEART FAILURE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial

Scott D. Solomon et al.

Summary: The DELIVER trial is an international, multicenter study that aims to evaluate the efficacy and safety of the SGLT2 inhibitor dapagliflozin in patients with heart failure with preserved and mildly reduced ejection fraction. The primary endpoint is time-to-first cardiovascular death or worsening heart failure event, to be assessed in both the full population and in those with specific ejection fraction criteria. DELIVER will provide insights into the role of dapagliflozin as an adjunct therapy in patients with heart failure.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection
Article Peripheral Vascular Disease

Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension

Alexandros Kasiakogias et al.

Summary: Hypertension is a major risk factor for HFpEF, and while specific guideline-directed medical therapy is not established, control of blood pressure is widely regarded as central to prevention and clinical care.

JOURNAL OF HYPERTENSION (2021)

Add to Collection
Article Medicine, General & Internal

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Stefan D. Anker et al.

Summary: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction

Christopher J. Rush et al.

Summary: In this cohort study, it was found that 91% of patients with HFpEF had evidence of epicardial CAD, CMD, or both. Among those without obstructive CAD, 81% had CMD. Patients with obstructive CAD experienced more adverse events during follow-up.

JAMA CARDIOLOGY (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction

Liam Gaziano et al.

Summary: This study aimed to develop race-specific and sex-specific risk prediction models for HFpEF and HFrEF using easily obtainable clinical variables. The models demonstrated good discrimination and calibration in a cohort of 1.8 million individuals, suggesting their potential utility in implementing preventive strategies or subtype-specific prevention trials in the VA healthcare system and general population after external validation.

ESC HEART FAILURE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

Biykem Bozkurt et al.

Summary: This document proposes a universal definition, revised stages, and new classification of heart failure based on left ventricular ejection fraction. The classification includes HF with reduced, mildly reduced, preserved, and improved ejection fraction, each with specific LVEF thresholds.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?

Gregory J. Wehner et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy

Jenica N. Upshaw et al.

JACC-CARDIOVASCULAR IMAGING (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

Scott D. Solomon et al.

CIRCULATION (2020)

Add to Collection
Editorial Material Cardiac & Cardiovascular Systems

Hyperdynamic left ventricular function and the prognostic implications for heart failure with preserved ejection fraction

Arnold C. T. Ng et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction

Jeong Hoon Yang et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction Detailed Phenotypes, Prognosis, and Response to Spironolactone

Jordana B. Cohen et al.

JACC-HEART FAILURE (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan

Senthil Selvaraj et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection
Article Oncology

Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)

Santa Cirmi et al.

CANCERS (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction

Karl-Patrik Kresoja et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Add to Collection
Review Cardiac & Cardiovascular Systems

Epidemiology of heart failure

Amy Groenewegen et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Add to Collection
Review Medicine, General & Internal

Heart Failure With Reduced Ejection Fraction A Review

Sean P. Murphy et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology)

Petar M. Seferovic et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Add to Collection
Article Medicine, General & Internal

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Paulus Kirchhof et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection
Article Medicine, General & Internal

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J. L. Heerspink et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection
Article Medicine, General & Internal

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

George L. Bakris et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection
Article Medicine, General & Internal

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

Christopher P. Cannon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction

Qing-wen Ren et al.

ESC HEART FAILURE (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Steve R. Ommen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection
Article Physiology

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction

Satyam Sarma et al.

PHYSIOLOGICAL REPORTS (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry

Yu Sato et al.

JOURNAL OF CARDIOLOGY (2019)

Add to Collection
Review Cardiac & Cardiovascular Systems

Heart Failure With Preserved Ejection Fraction and Diabetes JACC State-of-the-Art Review

Kelly McHugh et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology

Petar M. Seferovic et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

Ovidiu Chioncel et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Add to Collection
Review Cardiac & Cardiovascular Systems

Atrial Functional Mitral Regurgitation JACC Review Topic of the Week

Sebastien Deferm et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection
Article Medicine, General & Internal

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

V. Perkovic et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection
Article Medicine, General & Internal

Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study

Yogesh N. V. Reddy et al.

MAYO CLINIC PROCEEDINGS (2019)

Add to Collection
Meeting Abstract Cardiac & Cardiovascular Systems

Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, prognostic and therapeutic implications

D. Stolfo et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Burkert Pieske et al.

EUROPEAN HEART JOURNAL (2019)

Add to Collection
Article Physiology

Association of Chronic Kidney Disease with Preserved Ejection Fraction Heart Failure Is Independent of Baseline Cardiac Function

Thomas A. Mavrakanas et al.

KIDNEY & BLOOD PRESSURE RESEARCH (2019)

Add to Collection
Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

S. D. Solomon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure

Cristiana Vitale et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction

Jasper Tromp et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction A Randomized Controlled Trial

Yogesh N. V. Reddy et al.

CIRCULATION RESEARCH (2019)

Add to Collection
Article Medicine, General & Internal

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

S. D. Wiviott et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

Amil M. Shah et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease

Iris E. Beldhuis et al.

JACC-HEART FAILURE (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum Phenotyping, and Prognostic and Therapeutic Implications

Davide Stolfo et al.

JACC-HEART FAILURE (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

John G. F. Cleland et al.

EUROPEAN HEART JOURNAL (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction

Kathryn Dryer et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)

Add to Collection
Review Cardiac & Cardiovascular Systems

Ability of Nonstrain Diastolic Parameters to Predict Doxorubicin-Induced Cardiomyopathy: A Systematic Review With Meta-Analysis

Mohamed Nagiub et al.

CARDIOLOGY IN REVIEW (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction

Anna L. Beale et al.

CIRCULATION (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Anna B. Catino et al.

CIRCULATION-HEART FAILURE (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective internationalmulti-ethnic cohort study

Carolyn S. P. Lam et al.

EUROPEAN HEART JOURNAL (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

Petar M. Seferovic et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction

Tiew-Hwa Katherine Teng et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction

Koen W. Streng et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)

Add to Collection
Article Peripheral Vascular Disease

Serum uric acid is associated with incidence of heart failure with preserved ejection fraction and cardiovascular events in patients with arterial hypertension

Jun Gu et al.

JOURNAL OF CLINICAL HYPERTENSION (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction

Masaru Obokata et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Spectrum of Restrictive and Infiltrative Cardiomyopathies Part 2 of a 2-Part Series

Naveen L. Pereira et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Syed S. Mahmood et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Clinical Outcome of Isolated Tricuspid Regurgitation in Patients with Preserved Left Ventricular Ejection Fraction and Pulmonary Hypertension

Nir Bar et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2018)

Add to Collection
Article Medicine, General & Internal

Catheter Ablation for Atrial Fibrillation with Heart Failure

Nassir F. Marrouche et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection
Review Cardiac & Cardiovascular Systems

Primary and Secondary Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction

Marco Giuseppe Del Buono et al.

AMERICAN JOURNAL OF CARDIOLOGY (2018)

Add to Collection
Review Cardiac & Cardiovascular Systems

Chronotropic Incompetence in Chronic Heart Failure A State-of-the-Art Review

Alwin Zweerink et al.

CIRCULATION-HEART FAILURE (2018)

Add to Collection
Review Cardiac & Cardiovascular Systems

2018 ESC/ESH Guidelines for the management of arterial hypertension

Bryan Williams et al.

EUROPEAN HEART JOURNAL (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF

Sanjiv J. Shah et al.

EUROPEAN HEART JOURNAL (2018)

Add to Collection
Article Medicine, General & Internal

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Mathew S. Maurer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction

Eloy Dominguez et al.

ESC HEART FAILURE (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift

Filippo Crea et al.

EUROPEAN HEART JOURNAL (2017)

Add to Collection
Review Cardiac & Cardiovascular Systems

Heart rate and its reduction in chronic heart failure and beyond

Aleksandra Nikolovska Vukadinovic et al.

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

Ovidiu Chioncel et al.

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

A comprehensive population-based characterization of heart failure with mid-range ejection fraction

Angela S. Koh et al.

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial

Michel Komajda et al.

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure

Ambarish Pandey et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

Clyde W. Yancy et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Add to Collection
Letter Medicine, General & Internal

Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation

Simon de Denus et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection
Article Medicine, General & Internal

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Bruce Neal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Prevalence and Clinical Significance of Diabetes in Asian Versus White Patients With Heart Failure

Ingrid E. M. Bank et al.

JACC-HEART FAILURE (2017)

Add to Collection
Editorial Material Cardiac & Cardiovascular Systems

Blood Pressure Risk Associations in Heart Failure True Effects or Inverse Causality?

Michael Boehm et al.

JACC-HEART FAILURE (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure

Sang Eun Lee et al.

JACC-HEART FAILURE (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

The Transition From Hypertension to Heart Failure

Franz H. Messerli et al.

JACC-Heart Failure (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction

Masaru Obokata et al.

CIRCULATION (2017)

Add to Collection
Review Cardiac & Cardiovascular Systems

Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle?

Michele Senni et al.

CANADIAN JOURNAL OF CARDIOLOGY (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)

Soren L. Kristensen et al.

CIRCULATION (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction A Meta-Analysis of Published Study Data

Iris E. Beldhuis et al.

CIRCULATION-HEART FAILURE (2017)

Add to Collection
Review Oncology

Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis

Husam Abdel-Qadir et al.

CANCER TREATMENT REVIEWS (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

Scott D. Solomon et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)

Nazzareno Galie et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction

Erin D. Unger et al.

EUROPEAN JOURNAL OF HEART FAILURE (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry

Justin B. Echouffo-Tcheugui et al.

AMERICAN HEART JOURNAL (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications

Hiddo J. L. Heerspink et al.

CIRCULATION (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association of Central Adiposity With Adverse Cardiac Mechanics Findings From the Hypertension Genetic Epidemiology Network Study

Senthil Selvaraj et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2016)

Add to Collection
Review Cardiac & Cardiovascular Systems

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Piotr Ponikowski et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction

Katsuya Kajimoto et al.

EUROPEAN JOURNAL OF HEART FAILURE (2016)

Add to Collection
Review Cardiac & Cardiovascular Systems

Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation

Jozine M. ter Maaten et al.

EUROPEAN JOURNAL OF HEART FAILURE (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population-Based Adult Cohort: The Multiethnic Study of Atherosclerosis

Joseph Yeboah et al.

JOURNAL OF CARDIAC FAILURE (2016)

Add to Collection
Letter Cardiac & Cardiovascular Systems

Paradoxical Low-Gradient Aortic Stenosis The HFpEF of Aortic Stenosis

Calvin W. L. Chin et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Add to Collection
Article Peripheral Vascular Disease

Cardioprotective Effect of Thiazide-Like Diuretics: A Meta-Analysis

Peng Chen et al.

AMERICAN JOURNAL OF HYPERTENSION (2015)

Add to Collection
Review Medicine, General & Internal

Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease

Michael Boehm et al.

AMERICAN JOURNAL OF MEDICINE (2015)

Add to Collection
Article Endocrinology & Metabolism

Metabolic abnormalities of the heart in type II diabetes

Nelson Amaral et al.

DIABETES & VASCULAR DISEASE RESEARCH (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

Esther Gonzalez-Lopez et al.

EUROPEAN HEART JOURNAL (2015)

Add to Collection
Review Cardiac & Cardiovascular Systems

Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes

Petar M. Seferovic et al.

EUROPEAN HEART JOURNAL (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis

Joanne Simpson et al.

EUROPEAN JOURNAL OF HEART FAILURE (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Outcome and Impact of Aortic Valve Replacement in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis

Victor Dayan et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Roberto M. Lang et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)

Add to Collection
Article Medicine, General & Internal

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection
Article Medicine, General & Internal

Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure

Martin R. Cowie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Exercise Training in Patients With Heart Failure and Preserved Ejection Fraction Meta-Analysis of Randomized Control Trials

Ambarish Pandey et al.

CIRCULATION-HEART FAILURE (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction

Selma F. Mohammed et al.

CIRCULATION (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

Marc A. Pfeffer et al.

CIRCULATION (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Echocardiographic Diagnosis of Constrictive Pericarditis Mayo Clinic Criteria

Terrence D. Welch et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2014)

Add to Collection
Article Pharmacology & Pharmacy

Cardiovascular Effects of Current and Future Anti-Obesity Drugs

Simon Comerma-Steffensen et al.

CURRENT VASCULAR PHARMACOLOGY (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction

Mauro Gori et al.

EUROPEAN HEART JOURNAL (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study

Tsuyoshi Takada et al.

EUROPEAN JOURNAL OF HEART FAILURE (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT

Michel Komajda et al.

EUROPEAN JOURNAL OF HEART FAILURE (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)

Michael Boehm et al.

EUROPEAN JOURNAL OF HEART FAILURE (2014)

Add to Collection
Review Peripheral Vascular Disease

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials

Costas Thomopoulos et al.

JOURNAL OF HYPERTENSION (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Implications of Coronary Artery Disease in Heart Failure With Preserved Ejection Fraction

Seok-Jae Hwang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Add to Collection
Article Medicine, General & Internal

Spironolactone for Heart Failure with Preserved Ejection Fraction

Bertram Pitt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency

Carolyn S. P. Lam et al.

EUROPEAN HEART JOURNAL (2013)

Add to Collection
Article Cardiac & Cardiovascular Systems

Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing

Akiomi Yoshihisa et al.

EUROPEAN JOURNAL OF HEART FAILURE (2013)

Add to Collection
Review Cardiac & Cardiovascular Systems

Taking Diabetes to Heart-Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy

Marina Bayeva et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)

Add to Collection
Article Cardiac & Cardiovascular Systems

Clinical Features, Hemodynamics, and Outcomes of Pulmonary Hypertension Due to Chronic Heart Failure With Reduced Ejection Fraction Pulmonary Hypertension and Heart Failure

Wayne L. Miller et al.

JACC-HEART FAILURE (2013)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study

Viviane M. Conraads et al.

EUROPEAN JOURNAL OF HEART FAILURE (2012)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

Davide Castagno et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Add to Collection
Review Cardiac & Cardiovascular Systems

Chronotropic Incompetence Causes, Consequences, and Management

Peter H. Brubaker et al.

CIRCULATION (2011)

Add to Collection
Article Cardiac & Cardiovascular Systems

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study

Marco Guazzi et al.

CIRCULATION (2011)

Add to Collection
Article Cardiac & Cardiovascular Systems

Evidence of Atrial Functional Mitral Regurgitation Due to Atrial Fibrillation Reversal With Arrhythmia Control

Zachary M. Gertz et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Add to Collection
Article Peripheral Vascular Disease

Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction

Scott D. Solomon et al.

HYPERTENSION (2010)

Add to Collection
Article Cardiac & Cardiovascular Systems

Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy

Martina Krueger et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)

Add to Collection
Article Cardiac & Cardiovascular Systems

Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction

Barry A. Borlaug et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Add to Collection
Article Cardiac & Cardiovascular Systems

Central sleep apnoea syndrome in chronic heart failure: an underestimated and treatable comorbidity

M. Muller et al.

NETHERLANDS HEART JOURNAL (2010)

Add to Collection
Article Cardiac & Cardiovascular Systems

Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure)

Dirk J. van Veldhuisen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Add to Collection
Article Cardiac & Cardiovascular Systems

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction A Community-Based Study

Carolyn S. P. Lam et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Add to Collection
Article Cardiac & Cardiovascular Systems

Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial

John J. V. McMurray et al.

EUROPEAN JOURNAL OF HEART FAILURE (2008)

Add to Collection
Article Medicine, General & Internal

Treatment of hypertension in patients 80 years of age or older

Nigel S. Beckett et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection
Article Cardiac & Cardiovascular Systems

Cardiac steatosis in diabetes mellitus -: A 1H-magnetic resonance spectroscopy study

Jonathan M. McGavock et al.

CIRCULATION (2007)

Add to Collection
Article Cardiac & Cardiovascular Systems

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

John G. F. Cleland et al.

EUROPEAN HEART JOURNAL (2006)

Add to Collection
Review Biochemistry & Molecular Biology

NADPH oxidases in cardiovascular health and disease

Alison C. Cave et al.

ANTIOXIDANTS & REDOX SIGNALING (2006)

Add to Collection
Review Cardiac & Cardiovascular Systems

Diabetic cardiomyopathy - The search for a unifying hypothesis

IG Poornima et al.

CIRCULATION RESEARCH (2006)

Add to Collection
Article Cardiac & Cardiovascular Systems

Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus

P Herrero et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.